Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTBP2 | P56545 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | MGLL | Q99685 | 2/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | PAM | P19021 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3344609 | 1.00 | CTBP2 (0.43) | CTBP2TSHRMGLLCES2CES1 | |
| SCHEMBL10147069 | 0.79 | CTBP2 (0.47) | CTBP2TSHRCES2CES1AKR1B1 | |
| SCHEMBL2586905 | 0.75 | TSHR (0.53) | TSHRCES2CES1AKR1B1CNR2 | |
| SCHEMBL11654764 | 0.75 | CTBP2 (0.47) | CTBP2TSHRMGLLCES2CES1 | |
| SCHEMBL6616395 | 0.75 | TSHR (0.44) | TSHRCES2CES1AKR1B1CNR2 | |
| SCHEMBL11654767 | 0.75 | CTBP2 (0.47) | CTBP2TSHRMGLLCES2CES1 | |
| SCHEMBL9748148 | 0.71 | CTBP2 (0.47) | CTBP2TSHRMGLLCES2CES1 | |
| SCHEMBL9748142 | 0.71 | CTBP2 (0.47) | CTBP2TSHRMGLLCES2CES1 | |
| SCHEMBL10147072 | 0.70 | TSHR (0.44) | TSHRCES2CES1AKR1B1CNR2 | |
| SCHEMBL7875372 | 0.69 | CTBP2 (0.50) | CTBP2TSHRMGLLCES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8350092-B2 | Process of racemisation of optically active alpha aminoacetals | CLARIANT SPECIALTY FINE CHEMICALS (FRANCE) (FR) | 2013-01-08 | — | — | US | disclosed |
| EP-2162426-B1 | PROCESS OF RACEMISATION OF OPTICALLY ACTIVE ALPHA AMINOACETALS | CLARIANT SPECIALTY FINE CHEM F (FR) | 2013-01-02 | — | — | EP | disclosed |
| US-20100152490-A1 | Process Of Racemisation Of Optically Active Alpha Aminoacetals | CLARIANT SPECIALTY FINE CHEMICALS (FRANCE) (FR) | 2010-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152490-A1 | Process Of Racemisation Of Optically Active Alpha Aminoacetals | ALDH7A1, AADAT, ALAD | CTBP2 4498/4885TSHR 4710/4885MGLL 2562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.